Helga Gardarsdottir

May 9, 2024 | onlinelibrary.wiley.com | Rosa Gini |Romin Pajouheshnia |Helga Gardarsdottir |Dimitri Bennett

Key Points This is the first systematic exploration of approaches to describe diversity across data sources generating RWE, and the challenges and opportunities implied by such diversity. The review identified 91 documents offering recommendations and examples for characterizing diversity, or leveraging data diversity in pharmacoepidemiologic research. Our scoping review provides the basis for a framework to characterize data sources used to generate RWE.